Cyrcadia Asia

What Cyrcadia Asia does

Cyrcadia Asia is a Hong Kong–based (Sha Tin) for-profit, privately held health technology company founded in 2017, developing a wearable bra designed to detect breast cancer. The company operates at very small scale (1–10 employees) and is the Asia-Pacific vehicle for a wearable breast cancer detection platform, distinguishing it from generic breast self-examination or imaging-only screening by offering a continuous, sensor-driven monitoring form factor suited to periodic or everyday wear.

Its core product is a wearable garment incorporating sensors that capture breast tissue data (the public characterization emphasizes "accurate breast cancer detection"), with embedded firmware and detection algorithms translating signals into clinical outputs. No public patents, certifications, technical specifications, or validation studies were available in the source data, and the company's website was inaccessible at the time of data collection (verification/loading page), limiting technical depth. The Hong Kong base and iFlytek investment indicate an intended footprint across Greater China and Asia-Pacific.

The commercial business model is not explicitly disclosed in the available data — no pricing, distribution channels, customer segments, or revenue figures are documented. Strategic context (medical device category, regulatory-heavy pathway, presence of a chief medical officer) implies a regulated medical-device commercialization model (device sale, subscription, or clinical-channel partnership), supplemented potentially by data/AI services given the iFlytek alignment. To date, only one funding round is recorded: $3.8 million in July 2018, led by iFlytek, which anchors an AI-oriented strategic posture but provides no visibility into the current commercial pipeline.

Name

Cyrcadia Asia

Website

https://cyrcadia.asia

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Cyrcadia Asia is a Hong Kong–based health technology company, founded in 2017, that develops a wearable bra for breast cancer detection and targets the Asia-Pacific women's health and screening market.

Ownership category

akta.pro rank

Product category

Medical Wearables

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

akta.pro secondary industry

Mammography & Breast Imaging Systems (HLAHABAF)

Keywords

• Wearable health monitoring
• Breast cancer screening
• Medical wearables
• Smart bra technology
• Early cancer detection

Headquarters

HQ city

Sha Tin

HQ country

Hong Kong SAR China

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel

Core offering

Cyrcadia Asia develops a wearable smart bra embedded with sensors that monitors breast tissue and applies data analytics to enable early-stage breast cancer detection. The device is designed for women as a continuous, non-invasive screening aid and is positioned in the consumer health and preventive oncology category.

Differentiator

Problem solved

Functional benefit

Products and services

• Cyrcadia Wearable Smart Bra A sensor-embedded wearable bra designed for women to support early breast cancer detection through continuous monitoring and data analytics.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves4 records

Expansion highlights3 records

Broad incumbents

• GE HealthCare: GE HealthCare provides mammography, ultrasound, and AI-enabled breast imaging solutions globally. As a broad incumbent, it competes for hospital and imaging-center budgets allocated to breast cancer detection.
• Hologic: Hologic is a global leader in women's health imaging, including the dominant mammography and breast biopsy platforms (e.g., Genius 3D Mammography). It defines the diagnostic standard Cyrcadia Asia must beat or complement.
• Siemens Healthineers: Siemens Healthineers offers mammography and breast MRI systems used in hospital breast imaging workflows. It is an incumbent whose installed base and clinical relationships Cyrcadia Asia must navigate.

Emerging players

• iSono Health: iSono Health develops an automated, wearable 3D breast ultrasound system for at-home and clinic-based breast imaging. It is a direct analog in the wearable/portable breast imaging category targeting earlier and more frequent breast cancer detection.
• Lunit: Lunit is a Korean medical AI company whose Lunit INSIGHT product analyzes mammograms for cancer detection. As an Asia-based AI-imaging peer, it shares both the regional and competitive overlap with Cyrcadia Asia.
• Kheiron Medical Technologies: Kheiron Medical applies AI to mammography reading workflows (Mia), helping radiologists detect breast cancer earlier. It overlaps with Cyrcadia Asia's cancer-detection mission via AI, though delivered as clinician-facing software.
• Delphinus Medical Technologies: Delphinus developed SoftVue, a 3D whole-breast ultrasound tomography system for supplemental breast cancer screening. It is a niche emerging player with overlapping technology (novel imaging) and clinical use case.
• TheraCUES Technologies: TheraCUES is an emerging player in AI-augmented diagnostic imaging, including breast imaging analytics. It is comparable as a niche AI/diagnostic company targeting similar clinical workflows in cancer detection.

Direct peers

• Volpara Health: Volpara Health provides AI-driven breast density assessment and cancer risk prediction software used alongside mammography. It is a direct competitor in the software/AI-augmented breast cancer detection category, although its modality differs.
• Cyrcadia (US): The U.S.-based Cyrcadia, Inc. is the apparent parent/sister entity developing the original iTBra wearable sensor technology for breast cancer detection. It is the closest direct peer in product and category, with potential overlap in IP and market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cyrcadia Asia